Xiaofei is working as part of the Broad-Bayer Collaboration to support an early drug development program.
Xiaofei Yin is a Research Scientist in the Cardiovascular Disease Initiative (CVDi) at the Broad Institute of MIT and Harvard. She joined in January 2022, and is working as part of the Broad-Bayer Collaboration to support an early drug development program. Prior to joining the Broad Institute, she did her postdoctoral training in Dr. Danial Kelly lab, in the Cardiovascular Institute at University of Pennsylvania, where she studied the functions and mechanisms of MondoA in obesity and metabolic syndrome, as well as the role of Sdha in heart failure. Xiaofei obtained her Ph.D. in Biochemistry and Molecular Biology from University of Chinese Academy of Sciences, China, in 2017. Outside of the lab, she enjoys reading, baking, and spending time with her family and friends